| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | POWELL MICHAEL | 10% Owner | May 18, 2021 | Buy | $11.00 | 727,272 | 7,999,992 | 2,914,776 | May 18, 2021, 08:23 PM | |
| BOLT | Bolt Biotherapeutics, Inc. | POWELL MICHAEL | 10% Owner | Feb 09, 2021 | Buy | $20.00 | 450,000 | 9,000,000 | 2,754,437 | Feb 09, 2021, 06:04 PM | |
| CMPI | Checkmate Pharmaceuticals, Inc. | POWELL MICHAEL | Director | Aug 11, 2020 | Buy | $15.00 | 133,333 | 1,999,995 | 3,606,707 | Aug 12, 2020, 09:04 PM | |
| INZY | Inozyme Pharma, Inc. | POWELL MICHAEL | 10% Owner | Jul 28, 2020 | Buy | $16.00 | 437,500 | 7,000,000 | 2,028,308 | Jul 28, 2020, 06:08 PM | |
| AKUS | Akouos, Inc. | POWELL MICHAEL | 10% Owner | Jun 30, 2020 | Buy | $17.00 | 58,823 | 999,991 | 1,515,073 | Jul 01, 2020, 09:36 PM | |
| ITRM | Iterum Therapeutics plc | POWELL MICHAEL | 10% Owner | Jun 01, 2020 | Sale | $1.69 | 100,000 | 169,120 | 1,626,514 | Jun 03, 2020, 08:20 PM | |
| ITRM | Iterum Therapeutics plc | POWELL MICHAEL | 10% Owner | Jun 02, 2020 | Sale | $1.61 | 400,000 | 642,960 | 1,226,514 | Jun 03, 2020, 08:20 PM | |
| NXTC | NextCure, Inc. | POWELL MICHAEL | 10% Owner | Nov 15, 2019 | Buy | $36.75 | 150,000 | 5,512,500 | 2,671,856 | Nov 19, 2019, 09:47 PM | |
| GRTX | Galera Therapeutics, Inc. | POWELL MICHAEL | Director | Nov 12, 2019 | Buy | $12.00 | 750,000 | 9,000,000 | 3,083,712 | Nov 12, 2019, 04:17 PM | |
| NXTC | NextCure, Inc. | POWELL MICHAEL | 10% Owner | May 13, 2019 | Buy | $15.00 | 400,000 | 6,000,000 | 2,521,856 | May 15, 2019, 05:59 PM | |
| ETTX | Entasis Therapeutics Holdings Inc. | POWELL MICHAEL | 10% Owner | Sep 28, 2018 | Buy | $15.00 | 337,724 | 5,065,860 | 1,180,178 | Oct 02, 2018, 09:41 PM | |
| PRNB | Principia Biopharma Inc. | POWELL MICHAEL | 10% Owner | Sep 18, 2018 | Buy | $17.00 | 270,000 | 4,590,000 | 2,038,208 | Sep 20, 2018, 07:02 PM | |
| ITRM | Iterum Therapeutics plc | POWELL MICHAEL | 10% Owner | May 30, 2018 | Buy | $13.00 | 500,000 | 6,500,000 | 1,726,514 | May 30, 2018, 09:59 PM | |
| SYBX | SYNLOGIC, INC. | POWELL MICHAEL | Director | Jan 26, 2018 | Option Exercise | $9.75 | 150,000 | 1,462,500 | 574,972 | Jan 30, 2018, 04:30 PM | |
| OCRX | Ocera Therapeutics, Inc. | POWELL MICHAEL | Director | Sep 12, 2016 | Option Exercise | $1.04 | 28,776 | 29,842 | 705,368 | Dec 30, 2016, 06:51 PM | |
| MRNS | MARINUS PHARMACEUTICALS INC | POWELL MICHAEL | 10% Owner | Oct 20, 2016 | Sale | $1.39 | 750,683 | 1,042,699 | 1,134,851 | Oct 24, 2016, 04:49 PM | |
| OCRX | Ocera Therapeutics, Inc. | POWELL MICHAEL | Director | Jul 11, 2016 | Option Exercise | $1.26 | 11,969 | 15,081 | 11,969 | Jul 13, 2016, 08:32 PM | |
| ACRS | Aclaris Therapeutics, Inc. | POWELL MICHAEL | 10% Owner | Oct 13, 2015 | Buy | $11.00 | 409,090 | 4,499,990 | 2,289,480 | Oct 13, 2015, 01:26 PM | |
| MIRN | Mirna Therapeutics, Inc. | POWELL MICHAEL | Director | Oct 06, 2015 | Buy | $7.00 | 857,142 | 5,999,994 | 2,974,811 | Oct 06, 2015, 01:36 PM | |
| LIFE | aTYR PHARMA INC | POWELL MICHAEL | 10% Owner | May 12, 2015 | Buy | $14.00 | 320,000 | 4,480,000 | 1,866,126 | May 14, 2015, 09:19 PM | |
| HPTX | HYPERION THERAPEUTICS INC | POWELL MICHAEL | 10% Owner | May 07, 2015 | Option Exercise | $46.00 | 1,939,474 | 89,215,804 | 0 | May 08, 2015, 07:59 PM | |
| HSGX | HISTOGENICS CORP | POWELL MICHAEL | 10% Owner | Dec 08, 2014 | Option Exercise | $10.71 | 515,769 | 5,524,272 | 2,085,848 | Dec 10, 2014, 02:03 PM | |
| ALIM | ALIMERA SCIENCES INC | POWELL MICHAEL | 10% Owner | Sep 11, 2014 | Option Exercise | $2.66 | 2,506,270 | 6,666,678 | 2,506,270 | Sep 15, 2014, 04:41 PM | |
| MRNS | MARINUS PHARMACEUTICALS INC | POWELL MICHAEL | 10% Owner | Aug 05, 2014 | Buy | $8.00 | 750,683 | 6,005,464 | 1,859,639 | Aug 07, 2014, 12:43 PM | |
| AERI | AERIE PHARMACEUTICALS INC | POWELL MICHAEL | 10% Owner | Jul 10, 2014 | Sale | $25.81 | 8,022 | 207,030 | 0 | Jul 11, 2014, 09:40 PM | |
| AERI | AERIE PHARMACEUTICALS INC | POWELL MICHAEL | 10% Owner | Jul 09, 2014 | Sale | $24.00 | 1,000,000 | 24,001,301 | 1,566,657 | Jul 11, 2014, 09:40 PM | |
| AERI | AERIE PHARMACEUTICALS INC | POWELL MICHAEL | 10% Owner | May 22, 2014 | Sale | $16.00 | 323,932 | 5,182,912 | 2,766,657 | May 27, 2014, 04:55 PM | |
| VSAR | Versartis, Inc. | POWELL MICHAEL | 10% Owner | Mar 26, 2014 | Buy | $21.00 | 60,000 | 1,260,000 | 2,146,978 | Mar 28, 2014, 06:46 PM | |
| HPTX | HYPERION THERAPEUTICS INC | POWELL MICHAEL | 10% Owner | Mar 04, 2014 | Sale | $30.02 | 23,625 | 709,223 | 0 | Mar 05, 2014, 06:13 AM | |
| AERI | AERIE PHARMACEUTICALS INC | POWELL MICHAEL | 10% Owner | Oct 25, 2013 | Buy | $6.49 | 440,600 | 2,857,780 | 3,090,589 | Oct 30, 2013, 04:00 PM | |
| OCRX | Ocera Therapeutics, Inc. | POWELL MICHAEL | Director | Jul 15, 2013 | Buy | $6.03 | 391,166 | 2,357,323 | 1,025,364 | Jul 17, 2013, 05:49 PM | |
| HPTX | HYPERION THERAPEUTICS INC | POWELL MICHAEL | 10% Owner | Jul 31, 2012 | Buy | $10.00 | 563,000 | 5,630,000 | 2,947,221 | Aug 02, 2012, 07:57 PM | |
| DRTX | Durata Therapeutics, Inc. | POWELL MICHAEL | 10% Owner | Jul 24, 2012 | Buy | $9.00 | 588,236 | 5,294,124 | 2,271,330 | Jul 25, 2012, 03:31 PM | |
| TSRX | Trius Therapeutics Inc | POWELL MICHAEL | Director | Mar 26, 2012 | Option Exercise | $1.29 | 9,302 | 12,000 | 9,302 | Mar 27, 2012, 07:50 PM | |
| TSRX | Trius Therapeutics Inc | POWELL MICHAEL | Director | Jan 18, 2012 | Sale | $5.56 | 4,300 | 23,895 | 115,700 | Jan 20, 2012, 09:30 PM | |
| TSRX | Trius Therapeutics Inc | POWELL MICHAEL | Director | Jan 19, 2012 | Sale | $5.64 | 2,600 | 14,662 | 113,100 | Jan 20, 2012, 09:30 PM | |
| TSRX | Trius Therapeutics Inc | POWELL MICHAEL | Director | Jan 17, 2012 | Sale | $5.43 | 16,100 | 87,426 | 120,000 | Jan 17, 2012, 06:33 PM | |
| TSRX | Trius Therapeutics Inc | POWELL MICHAEL | Director | Jan 13, 2012 | Sale | $5.46 | 8,522 | 46,568 | 136,100 | Jan 17, 2012, 06:33 PM | |
| ANTH | Anthera Pharmaceuticals Inc | POWELL MICHAEL | 10% Owner | Dec 30, 2011 | Sale | $6.22 | 25,000 | 155,625 | 3,298,684 | Jan 03, 2012, 08:31 PM | |
| ANTH | Anthera Pharmaceuticals Inc | POWELL MICHAEL | 10% Owner | Dec 21, 2011 | Sale | $6.51 | 25,000 | 162,770 | 3,339,944 | Dec 23, 2011, 06:22 PM | |
| ANTH | Anthera Pharmaceuticals Inc | POWELL MICHAEL | 10% Owner | Dec 22, 2011 | Sale | $6.22 | 25,000 | 155,605 | 3,319,314 | Dec 23, 2011, 06:22 PM | |
| ANTH | Anthera Pharmaceuticals Inc | POWELL MICHAEL | 10% Owner | Mar 04, 2010 | Option Exercise | $6.30 | 1,994,850 | 12,560,454 | 3,360,574 | Dec 22, 2011, 06:24 PM | |
| AMRN | AMARIN CORP PLCUK | POWELL MICHAEL | 10% Owner | Mar 29, 2011 | Sale | $7.25 | 424,900 | 3,080,610 | 8,513,388 | Mar 31, 2011, 03:16 PM | |
| AMRN | AMARIN CORP PLCUK | POWELL MICHAEL | 10% Owner | Mar 24, 2011 | Sale | $7.56 | 500,000 | 3,778,000 | 9,013,388 | Mar 28, 2011, 08:37 PM | |
| AMRN | AMARIN CORP PLCUK | POWELL MICHAEL | 10% Owner | Mar 25, 2011 | Sale | $7.50 | 75,100 | 563,333 | 8,938,288 | Mar 28, 2011, 08:37 PM | |
| AMRN | AMARIN CORP PLCUK | POWELL MICHAEL | 10% Owner | Mar 09, 2011 | Sale | $7.25 | 30,700 | 222,575 | 12,119,688 | Mar 11, 2011, 09:27 PM | |
| AMRN | AMARIN CORP PLCUK | POWELL MICHAEL | 10% Owner | Mar 10, 2011 | Sale | $7.26 | 606,300 | 4,400,283 | 11,513,388 | Mar 11, 2011, 09:27 PM | |
| AMRN | AMARIN CORP PLCUK | POWELL MICHAEL | 10% Owner | Feb 25, 2011 | Sale | $8.13 | 363,000 | 2,952,787 | 12,150,388 | Mar 01, 2011, 05:24 PM | |
| OREX | Orexigen Therapeutics, Inc. | POWELL MICHAEL | Director | Dec 21, 2010 | Sale | $8.38 | 375,339 | 3,145,116 | 371,184 | Dec 23, 2010, 06:18 PM | |
| OREX | Orexigen Therapeutics, Inc. | POWELL MICHAEL | Director | Dec 22, 2010 | Sale | $8.30 | 250,721 | 2,081,661 | 164,289 | Dec 23, 2010, 06:18 PM | |
| OREX | Orexigen Therapeutics, Inc. | POWELL MICHAEL | Director | Dec 23, 2010 | Sale | $8.09 | 198,940 | 1,609,504 | 0 | Dec 23, 2010, 06:18 PM | |
| OREX | Orexigen Therapeutics, Inc. | POWELL MICHAEL | Director | Dec 17, 2010 | Sale | $8.76 | 131,254 | 1,149,575 | 949,104 | Dec 21, 2010, 05:34 PM | |
| OREX | Orexigen Therapeutics, Inc. | POWELL MICHAEL | Director | Dec 20, 2010 | Sale | $8.50 | 325,000 | 2,763,995 | 680,914 | Dec 21, 2010, 05:34 PM | |
| TSRX | Trius Therapeutics Inc | POWELL MICHAEL | Director | Aug 06, 2010 | Option Exercise | $4.68 | 1,723,395 | 8,063,070 | 3,615,572 | Aug 10, 2010, 01:55 PM |
Menu